Logo

Prahlad Singh

Dec 10, 2018

Prahlad Singh has been appointed president and chief operating officer of PerkinElmer, effective Jan. 1, 2019. Singh will be responsible for the Discovery and analytical solutions and the diagnostics operating divisions. He joined PerkinElmer in 2014 as president of the diagnostics business, was elected as an officer in 2016 and executive vice president in 2016. Prior to joining the firm, Singh served as general manager of GE Healthcare's women's health business. He has also held senior executive level positions in strategy, business development, and M&A at GE and at Philips Healthcare.


Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.